BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15133478)

  • 1. Expression of cytokeratin by malignant meningiomas: diagnostic pitfall of cytokeratin to separate malignant meningiomas from metastatic carcinoma.
    Liu Y; Sturgis CD; Bunker M; Saad RS; Tung M; Raab SS; Silverman JF
    Mod Pathol; 2004 Sep; 17(9):1129-33. PubMed ID: 15133478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningiomas and arachnoid cells: an immunohistochemical study of epithelial markers.
    Ng HK; Tse CC; Lo ST
    Pathology; 1987 Jul; 19(3):253-7. PubMed ID: 2448733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative evaluation of immunohistochemical markers for the differential diagnosis of malignant pleural tumours.
    Garcia-Prats MD; Ballestin C; Sotelo T; Lopez-Encuentra A; Mayordomo JI
    Histopathology; 1998 May; 32(5):462-72. PubMed ID: 9639123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation.
    Sangoi AR; Dulai MS; Beck AH; Brat DJ; Vogel H
    Am J Surg Pathol; 2009 May; 33(5):669-81. PubMed ID: 19194275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningioma, meningeal hemangiopericytoma (angioblastic meningioma), peripheral hemangiopericytoma, and acoustic schwannoma. A comparative immunohistochemical study.
    Winek RR; Scheithauer BW; Wick MR
    Am J Surg Pathol; 1989 Apr; 13(4):251-61. PubMed ID: 2648875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical evidence for mesothelial origin of paratesticular adenomatoid tumour.
    Delahunt B; Eble JN; King D; Bethwaite PB; Nacey JN; Thornton A
    Histopathology; 2000 Feb; 36(2):109-15. PubMed ID: 10672054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretory meningioma: clinical, histologic, and immunohistochemical findings in 31 cases.
    Probst-Cousin S; Villagran-Lillo R; Lahl R; Bergmann M; Schmid KW; Gullotta F
    Cancer; 1997 May; 79(10):2003-15. PubMed ID: 9149029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of the keratin polypeptides in meningiomas of different types: an immunohistochemical analysis of 463 cases.
    Miettinen M; Paetau A
    Hum Pathol; 2002 Jun; 33(6):590-8. PubMed ID: 12152157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum.
    Attanoos RL; Webb R; Dojcinov SD; Gibbs AR
    Histopathology; 2002 Mar; 40(3):237-44. PubMed ID: 11895489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wide spectrum screening keratin as a marker of metaplastic spindle cell carcinoma of the breast: an immunohistochemical study of 24 patients.
    Adem C; Reynolds C; Adlakha H; Roche PC; Nascimento AG
    Histopathology; 2002 Jun; 40(6):556-62. PubMed ID: 12047767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differential immunohistochemical characteristics of meningiomas and other neoplasms of the central nervous system].
    Pérez-Bacete MJ; Cerdá-Nicolás M; Piquer J; Peydró-Olaya A
    Arch Neurobiol (Madr); 1989; 52(6):265-72. PubMed ID: 2635847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial differentiation in meningiomas. An immunohistochemical, histochemical, and ultrastructural study--with review of the literature.
    Radley MG; di Sant'Agnese PA; Eskin TA; Wilbur DC
    Am J Clin Pathol; 1989 Sep; 92(3):266-72. PubMed ID: 2476026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningiomas. An immunohistochemical study of 50 cases.
    Meis JM; Ordóñez NG; Bruner JM
    Arch Pathol Lab Med; 1986 Oct; 110(10):934-7. PubMed ID: 2429637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical comparison of chordoma with chondrosarcoma, myxopapillary ependymoma, and chordoid meningioma.
    Cho HY; Lee M; Takei H; Dancer J; Ro JY; Zhai QJ
    Appl Immunohistochem Mol Morphol; 2009 Mar; 17(2):131-8. PubMed ID: 19521276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial membrane antigen and cytokeratin expression by meningiomas: an immunohistological study.
    Theaker JM; Gatter KC; Esiri MM; Fleming KA
    J Clin Pathol; 1986 Apr; 39(4):435-9. PubMed ID: 2422220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory meningioma: immunohistochemical findings and evaluation of mast cell infiltration.
    Tirakotai W; Mennel HD; Celik I; Hellwig D; Bertalanffy H; Riegel T
    Neurosurg Rev; 2006 Jan; 29(1):41-8. PubMed ID: 16010579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignant meningioma with adenocarcinoma-like metaplasia: a rare entity to be not misdiagnosed].
    Marguet F; Proust F; Crahes M; Basset C; Joly-Helas G; Chambon P; Laquerrière A
    Ann Pathol; 2014 Jun; 34(3):223-7. PubMed ID: 24950872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of epithelial and keratin markers in glioblastoma multiforme: an immunohistochemical study.
    Oh D; Prayson RA
    Arch Pathol Lab Med; 1999 Oct; 123(10):917-20. PubMed ID: 10506444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma.
    Ordóñez NG
    Am J Surg Pathol; 2003 Aug; 27(8):1031-51. PubMed ID: 12883236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial markers in malignant melanoma. A study of primary lesions and their metastases.
    Ben-Izhak O; Stark P; Levy R; Bergman R; Lichtig C
    Am J Dermatopathol; 1994 Jun; 16(3):241-6. PubMed ID: 7524376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.